About Us
Innovative Drugs
Innovation Platform
News
Join Us
Contact Us
Keyword:
Latest News
New Progress in Autoimmune Disease Pipeline! Vcare PharmaTech's VC005 Topical Gel Secures China IND Approval for Plaque Psoriasis
Vcare PharmaTech Enters into Exclusive Licensing Agreement with Everest Medicines for Sumecigrel Across Multiple Asia-Pacific Countries and Regions
Eratrectinib, the next-generation TRK inhibitor independently developed by Vcare PharmaTech, has received marketing approval
Capital Empowers Innovation: Vcare PharmaTech Completes Nearly RMB 200 Million Series C3 Financing
The Fourth Self-Developed Innovative Drug Enters Pivotal Clinical Stage! Jiangsu Vcare’s VC005 Topical Gel Completes First Patient Enrollment in Phase III Clinical Trial
New Expansion in Topical Pipeline! Jiangsu Vcare’s VC005 Topical Gel Granted China IND Approval for New Indication of Vitiligo